Abstract:Background: Osteoarthritis (OA) is the most common joint degenerative disease, and so far, there is no effective therapy to prevent or delay its development. Considerable attention is now being given to the impact of m6A RNA methylation modification on the disease immune regulation. However, much remains unknown about the function of m6A modification in OA. Methods: A total of 63 OA and 59 healthy samples were applied to comprehensively examine the m6A regulators mediated RNA methylation modification pattern in OA, and evaluate the impacts of distinct patterns on the characteristics of OA immune microenvironment, including immune infiltration cells, immune responses and human leukocyte antigen (HLAs) genes expression. In addition, we screened out the m6A phenotype-related genes and further explored their potential biological functions. At last, we verified the expression of key m6A regulators and their associations with immune cells, in vitro . Results: Most of m6A regulators was differentially expressed in OA samples compared to the normal tissues. Based on six hub-m6A regulators identified as abnormally expressed in OA samples, we developed a classifier to distinguish OA patients from healthy individuals. We noted that immune characteristics of OA were correlated with m6A regulators. For instance, YTHDF2 had a strongest significantly positive correlation with regulatory T cells (Tregs) and IGFBP2 was strongest negatively associated with dendritic cells (DCs), which were confirmed by the immunohistochemistry (IHC) staining. Two distinct m6A modification patterns were determined: pattern B had higher infiltrating immunocytes and more active immune responses than pattern A, and two patterns differed in the expression of HLA genes. We also identified 1,592 m6A phenotype-related genes that could mediate the OA synovitis and cartilage degradation by the PI3K-Akt signaling pathway. Quantitative real-time polymerase chain reaction (qRT-PCR) results indicated that IGFBP2 was significantly overexpressed, while YTHDF2 mRNA expression was decreased in OA samples, which was consistent with our findings. Conclusion: Our research proves the essential impact of m6A RNA methylation modification on the OA immune microenvironment, and helps to explain the regulatory mechanism behind it, which may open up a new direction for more precise immunotherapy of osteoarthritis.

FTO-mediated m6A demethylation of pri-miR-3591 alleviates osteoarthritis progression

FTO-mediated SMAD2 m6A modification protects cartilage against Osteoarthritis

FTO-mediated RNA m6A methylation regulates synovial aggression and inflammation in rheumatoid arthritis

The emerging roles of N6-methyladenosine in osteoarthritis

The m6A demethylase FTO promotes the osteogenesis of mesenchymal stem cells by downregulating PPARG

FTO-overexpressing extracellular vesicles from BM-MSCs reverse cellular senescence and aging to ameliorate osteoarthritis by modulating METTL3/YTHDF2-mediated RNA m6A modifications

Regulatory Role of N6-Methyladenosine (m6A) Modification in Osteoarthritis

FTO regulates adipogenesis by controlling cell cycle progression via mA-YTHDF2 dependent mechanism.

M6a Mrna Methylation Controls Autophagy and Adipogenesis by Targeting Atg5 and Atg7

Comprehensive analysis of the m6A demethylase FTO in endothelial dysfunction by MeRIP sequencing

Comprehensive analysis of m6A RNA methylation modification patterns and the immune microenvironment in osteoarthritis

N6-methyladenosine (m6A) methyltransferase WTAP-mediated miR-92b-5p accelerates osteoarthritis progression

FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis

Critical roles of FTO-mediated mRNA m6A demethylation in regulating adipogenesis and lipid metabolism: Implications in lipid metabolic disorders

m6A regulator-mediated methylation modification patterns and immune microenvironment infiltration characterization in osteoarthritis

Vascular Smooth Muscle FTO Promotes Aortic Dissecting Aneurysms via m6A Modification of Klf5

Overview of distinct N6-Methyladenosine profiles of messenger RNA in osteoarthritis

WTAP-mediated m6A modification of FRZB triggers the inflammatory response via the Wnt signaling pathway in osteoarthritis

m 6 A methylation modulates adipogenesis through JAK2-STAT3-C/EBPβ signaling.

Knockdown of fat mass and obesity alleviates the ferroptosis in Parkinson's disease through m6A‐NRF2‐dependent manner

m6A Regulator-Mediated RNA Methylation Modification Patterns Regulate the Immune Microenvironment in Osteoarthritis